Silicon Laboratories › Financials
Ten years from Silicon Laboratories’ own SEC filings. Fiscal years end in January.
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Jan 2021fiscal year | Jan 2022fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Jan 2026fiscal year | Last 12 monthsto Jul 2026 | Latest quarterJul 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $697.6M | $768.9M | $868.3M | $473.8M | $510.9M | $720.9M | $1.02B | $782.3M | $584.4M | $784.8M | $855.9M | — |
| Gross profit | $421.5M | $454.2M | $521.4M | $280.2M | $294.8M | $425.4M | $642.6M | $460.6M | $312.2M | $457.0M | $518.8M | — |
| Operating income | $66.3M | $85.0M | $85.2M | −$88.6M | −$107.1M | −$32.8M | $119.3M | −$24.2M | −$165.5M | −$70.5M | −$43.3M | — |
| Net income | $61.5M | $47.1M | $83.6M | $19.3M | $12.5M | $2.12B | $91.4M | −$34.5M | −$191.0M | −$64.9M | −$39.1M | — |
| Earnings per share, diluted | $1.45 | $1.09 | $1.90 | $0.43 | $0.28 | $47.78 | $2.54 | −$1.09 | −$5.93 | −$1.98 | — | — |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Jan 2021fiscal year | Jan 2022fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Jan 2026fiscal year | Last 12 monthsto Jul 2026 | Latest quarterJul 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $141.1M | $269.4M | $197.0M | $227.1M | $202.7M | $1.07B | $499.9M | $227.5M | $281.6M | $364.2M | — | $362.2M |
| Total assets | $1.08B | $1.54B | $1.62B | $1.67B | $1.99B | $2.96B | $2.17B | $1.44B | $1.22B | $1.27B | — | $1.25B |
| Debt | $72.5M | $341.9M | $354.8M | $368.3M | $563.4M | — | $529.6M | — | — | — | — | — |
| Total liabilities | $254.9M | $582.1M | $557.1M | $559.8M | $793.6M | $745.9M | $764.4M | $234.4M | $142.7M | $174.9M | — | $158.3M |
| Shareholders' equity | $827.0M | $953.0M | $1.07B | $1.12B | $1.20B | $2.21B | $1.41B | $1.21B | $1.08B | $1.09B | — | $1.09B |
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Jan 2021fiscal year | Jan 2022fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Jan 2026fiscal year | Last 12 monthsto Jul 2026 | Latest quarterJul 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $128.9M | $189.5M | $173.5M | $166.5M | $135.7M | $91.2M | $141.3M | −$30.3M | −$13.9M | $95.7M | $33.1M | — |
| Capital spending | $10.9M | $12.3M | $24.5M | $15.3M | $18.1M | $28.6M | $26.5M | $22.3M | $11.7M | $29.9M | $38.5M | — |
| Free cash flow | $118.0M | $177.3M | $149.1M | $151.2M | $117.6M | $62.6M | $114.7M | −$52.6M | −$25.7M | $65.8M | −$5.4M | — |
| Buybacks | $40.5M | — | $39.3M | $26.7M | $16.3M | $1.15B | $883.4M | $217.1M | $16K | $0 | — | — |
| Returned to shareholders | $40.5M | — | $39.3M | $26.7M | $16.3M | $1.15B | $883.4M | $217.1M | $16K | $0 | — | — |
| Stock-based pay | $39.6M | $44.8M | $50.1M | $44.3M | $49.5M | $56.8M | $60.5M | $48.2M | $61.5M | $80.3M | $87.4M | — |
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
$7.37B at $221.00 a share, with 33,366,761 shares outstanding as of Aug 4, 2026, from the cover of its latest SEC filing.
Revenue of $855.9M and net income of -$39.1M in the last 12 months to Jul 2026.
Silicon Laboratories reported $362.2M of cash and equivalents on its balance sheet in Jul 2026.
No. Operating cash flow minus capital spending was -$5.4M in the last 12 months to Jul 2026.
Free. Your email goes to Substack, which runs the newsletter. Privacy